ASCEnD Randomises Its 50th Participant

Congratulations to Avon & Wiltshire Mental Health Partnership Trust for recruiting the 50th ASCEnD participant.

Last week, the ASCEnD trial randomised its 50th participant to either the Aripiprazole/ Sertraline combination or quetiapine. We would like to thank all the participants, past and present, for their time and contribution to the ASCEnD study.